Mirati Therapeutics, Inc.
MRTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2,548 | $7,611 | $9,881 | $4,828 |
| - Cash | $235 | $413 | $1,390 | $415 |
| + Debt | $52 | $46 | $42 | $0 |
| Enterprise Value | $2,364 | $7,244 | $8,533 | $4,413 |
| Revenue | $12 | $72 | $13 | $3 |
| % Growth | -82.7% | 438.1% | 301.7% | – |
| Gross Profit | $12 | -$437 | -$286 | -$180 |
| % Margin | 95.2% | -605.5% | -2,134.3% | -5,383.2% |
| EBITDA | -$757 | -$571 | -$369 | -$222 |
| % Margin | -6,084.4% | -792.6% | -2,752.1% | -6,652.3% |
| Net Income | -$741 | -$582 | -$358 | -$213 |
| % Margin | -5,957.4% | -807% | -2,671.6% | -6,394.5% |
| EPS Diluted | -13.18 | -11.21 | -7.96 | -5.69 |
| % Growth | -17.6% | -40.8% | -39.9% | – |
| Operating Cash Flow | -$571 | -$389 | -$272 | -$148 |
| Capital Expenditures | -$5 | -$10 | -$4 | -$2 |
| Free Cash Flow | -$575 | -$399 | -$276 | -$149 |